| Robyn Hart, PHARMD | |
|
2000 W Dimond Blvd, Anchorage, AK 99515-1469 | |
| (907) 267-6733 | |
| Not Available |
| Full Name | Robyn Hart |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2000 W Dimond Blvd, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316629009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH-4675 (Hawaii) | Secondary |
| 183500000X | Pharmacist | 161412 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robyn Hart, PHARMD 7710 Evander Dr, Anchorage, AK 99518-3103 Ph: (808) 557-0065 | Robyn Hart, PHARMD 2000 W Dimond Blvd, Anchorage, AK 99515-1469 Ph: (907) 267-6733 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
GE is helping to transform the delivery of patient care with Venue™ 40, a miniaturized ultrasound system with advanced touch-screen technology, launched by GE Healthcare, a business unit of General Electric Company. Venue 40 is portable, allowing physicians to quickly perform rapid diagnostics and needle-guided procedures right at a patient's bedside, providing real-time results.
One in every 50 people screened for a suspected sexually transmitted infection (STI) in the Emergency Department at Henry Ford Hospital was found to be infected with HIV using a rapid blood sample screening test.
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
› Verified 6 days ago
Ciara M Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Pharmacy Dept, Anchorage, AK 99517 Phone: 907-339-0560 | |
Kelly Cutrer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12045 Brandon St, Anchorage, AK 99515 Phone: 907-631-0300 Fax: 907-631-0632 | |
Dr. Kyle Patrick Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 673 Mdg / Sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2778 | |
Dr. Remi Cristen Williamson, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-2117 | |
Evan Michael Ambrose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 W Northern Lights Blvd, Anchorage, AK 99517 Phone: 907-339-0560 | |
Timothy Paul Stone, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-332-1004 | |
Jordan E Bell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3260 Providence Dr Ste C520, Anchorage, AK 99508 Phone: 907-212-3420 Fax: 907-212-3429 |